Maxillary Canine Retraction Assisted With Micro-osteoperforations Versus Injectable Platelet Rich Fibrin

Al-Azhar University

Status and phase: Invitation-only; Phase 2

Conditions: Effects of; Movement of Teeth Assiste Wit MOPS and I-prf

Treatments: Combination Product: injectable platelet rich fibrin versus microosteoperforation

Study type: Interventional

Funder types: Other

Identifiers

NCT05960825

857/140

Details and patient eligibility

About

The present clinical comparative study will be undertaken for assessment of two different modalities of maxillary canine retraction assisted with microosteoperforations versus injectable platelet rich fibrin.

Full description

Group I: will include 9 patients who willreceive MOPs with maxillary canine retraction that will be performed on intervention sides according to a standardized protocol.

▪ Group II: will include 9 patients receive i-PRF that will be performed on intervention sides according to a standardized protocol.

Enrollment: 18 estimated patients

Sex: All

Ages: 15 to 22 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. An age ranges from 15-22 years.
2. Severe crowding or protrusion requiring 1st premolars extractions followed by symmetrical canine retraction.
3. All permanent teeth present, 3rd molars are excluded.
4. Good oral and general health.
5. No systemic disease/medication that could interfere with OTM.
6. No previous orthodontic treatment.

Exclusion criteria

1. Patient diagnosed to have an indication for non-extraction approach.
2. Poor oral hygiene or periodontally compromised patient.
3. Patient with craniofacial anomalies or previous history of trauma, bruxism or parafunctions.
4. Previous orthodontic treatment.

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

18 participants in 4 patient groups

Group MOPs

Experimental group

Description:

Group MOPs : will include 9 patients who willreceive MOPs with maxillary canine retraction that will be performed on intervention sides according to a standardized protocol.

Treatment:

Combination Product: injectable platelet rich fibrin versus microosteoperforation

Group IMOPS

No Intervention group

Description:

other side in group which is control group

Group i-PRF

Experimental group

Description:

group i-PRF: will include 9 patients receive i-PRF that will be performed on intervention sides according to a standardized protocol

Treatment:

Combination Product: injectable platelet rich fibrin versus microosteoperforation

group i-PRF2

No Intervention group

Description:

other side in group which is control group